Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,876–4,900 of 7,816 matching trials · page 196 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient NCT04977011 relaxing music Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 196 | Min-Sheng General Hospital OTHER |
2021-07-26 |
|
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study NCT02420756 PET Scan Runs in: United States · 2 sites |
NA other |
COMPLETED | 18,488 | American College of Radiology OTHER |
2021-07-23 |
|
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) NCT03305809 LY3154207; Placebo Runs in: Canada; Puerto Rico; United States · 77 sites |
PHASE2 other |
COMPLETED | 344 | Eli Lilly and Company INDUSTRY |
2021-07-23 |
|
Home-Based Telerehabilitation for People With Alzheimer Disease NCT04606251 Exercise Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 34 | Istanbul University - Cerrahpasa OTHER |
2021-07-22 |
|
Physical Exercise for Prevention of Dementia NCT02236416 Intervention group; Control group Runs in: Italy · 1 site |
NA other |
COMPLETED | 1,000 | University of Molise OTHER |
2021-07-21 |
|
Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease NCT03625622 AR1001; Placebo Runs in: United States · 21 sites |
PHASE2 other |
COMPLETED | 210 | AriBio Co., Ltd. INDUSTRY |
2021-07-21 |
|
Initial Investigation of [18F]P16-129 in Alzheimer's Disease Patients and Healthy Volunteers NCT03902548 [18F]P16-129 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 14 | Five Eleven Pharma, Inc. INDUSTRY |
2021-07-20 |
|
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease NCT02006472 Pridopidine; Placebo Runs in: Australia; Austria; Canada; Denmark; France; Germany; Ita... · 58 sites |
PHASE2 other |
COMPLETED | 408 | Prilenia INDUSTRY |
2021-07-19 |
|
MIND: Care Coordination for Community-living Person With Dementia NCT02396082 MIND-S Intervention; Augmented Usual Care Runs in: United States · 1 site |
NA other |
COMPLETED | 300 | Johns Hopkins University OTHER |
2021-07-16 |
|
Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014 NCT03267992 COPD Co-Pilot AIR App Runs in: Switzerland · 2 sites |
NA other |
TERMINATED | 9 | Boston Scientific Corporation INDUSTRY |
2021-07-16 |
|
A Phase I Study of GT300 in Healthy Subjects NCT04963855 GT300; Microcrystalline cellulose |
PHASE1 other |
UNKNOWN | 56 | Generian Pharmaceuticals, Inc. INDUSTRY |
2021-07-15 |
|
Board Game Intervention to Improve Cognitive and Daily Functioning NCT04964011 Board game intervention Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 68 | Yang Shang-Yu OTHER |
2021-07-15 |
|
Evaluation of the Effectiveness of the TOVERTAFEL System on Behavioral Disorders NCT04421833 TOVERTAFEL; USUAL activities Runs in: France · 1 site |
NA other |
UNKNOWN | 48 | Hospices Civils de Lyon OTHER |
2021-07-14 |
|
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM® NCT04954534 human umbilical cord blood derived mesenchymal stem cells Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 9 | Samsung Medical Center OTHER |
2021-07-14 |
|
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China NCT04961450 Runs in: China · 1 site |
NA other |
ENROLLING_BY_INVITATION | 2,500 | Peking University Third Hospital OTHER |
2021-07-14 |
|
Study of Motor Representations in Healthy Subjects and Amnestic MCI NCT02574182 Brain MRI Runs in: France · 1 site |
NA other |
COMPLETED | 97 | University Hospital, Angers OTHER_GOV |
2021-07-12 |
|
Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill NCT04958512 Yangxue Qingnao pill; Hydergotoxine mesylate tablets; blank control group Runs in: China · 1 site |
NA other |
COMPLETED | 60 | Peking University Third Hospital OTHER |
2021-07-12 |
|
Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study NCT02092987 Social work support; Educational material; NYU caregiver counseling... Runs in: United States · 1 site |
NA other |
COMPLETED | 221 | Columbia University OTHER |
2021-07-09 |
|
Trial of Oxaloacetate in Alzheimer's Disease (TOAD) NCT02593318 Oxaloacetate (OAA) 1g; Oxaloacetate (OAA) 2g Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 32 | Russell Swerdlow OTHER |
2021-07-09 |
|
Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline NCT04585880 Virtual Collaborative Care Clinic Runs in: United States · 1 site |
NA other |
COMPLETED | 33 | University of Kansas Medical Center OTHER |
2021-07-09 |
|
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease NCT02565511 CAD106 Immunotherapy; Placebo to CAD106; CNP520; Placebo to CNP520; Alum Runs in: Australia; Belgium; Canada; Finland; Germany; Netherlands... · 129 sites |
PHASE2|PHASE3 other |
TERMINATED | 480 | Novartis Pharmaceuticals INDUSTRY |
2021-07-08 |
|
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS NCT02686268 Runs in: Netherlands; United States · 8 sites |
NA other |
COMPLETED | 128 | Washington University School of Medicine OTHER |
2021-07-08 |
|
Brain Stimulation and Enhancing Cognition in Older Adults NCT03653351 Active Transcranial Direct Current Stimulation (tDCS); Sham Transcr... Runs in: United States · 2 sites |
NA other |
COMPLETED | 26 | Washington University School of Medicine OTHER |
2021-07-08 |
|
Bright Light Therapy in Older Adults With Moderate to Very Severe Dementia NCT04949984 Bright light therapy Runs in: Spain · 1 site |
NA other |
COMPLETED | 39 | Universidade da Coruña OTHER |
2021-07-08 |
|
Intranasal Insulin for the Treatment of HAND NCT03081117 Insulin, intranasal; Placebo, intranasal Runs in: United States · 1 site |
PHASE1|PHASE2 other |
TERMINATED | 21 | Johns Hopkins University OTHER |
2021-07-07 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial